Lnctac
Chengdu, CN · 1 known investors
Lingtaike Biotech develops nucleic acid drugs based on lncRNA, using its proprietary lncRNA-mediated targeting chimera technology (lncTAC) combined with the UNAST platform to target traditionally undruggable disease targets. The company focuses on drug discovery for unmet clinical needs in the lncRNA field.
Founders & leadership
宋
宋旭Professor / Founder
Investors · 1
Frequently asked questions
- What does Lnctac do?
- Lingtaike Biotech develops nucleic acid drugs based on lncRNA, using its proprietary lncRNA-mediated targeting chimera technology (lncTAC) combined with the UNAST platform to target traditionally undruggable disease targets. The company focuses on drug discovery for unmet clinical needs in the lncRNA field.
- Who founded Lnctac?
- Lnctac was founded by 宋旭.
- Who are Lnctac's investors?
- Lnctac's investors include Pan-Lin Capital.
- Where is Lnctac headquartered?
- Lnctac is headquartered in Chengdu, CN.